Previous 10 | Next 10 |
2023-11-08 04:55:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. Headwaters Capital Management's portfolio declined by 7.6% in Q3 2023, compared to a 4.7% return for the Russell Mi...
2023-11-06 16:05:03 ET More on Abcam ADS, Danaher, etc. Why Danaher Is One Of My Favorite Long-Term Investments Danaher Corporation (DHR) Q3 2023 Earnings Call Transcript Danaher Corporation 2023 Q3 - Results - Earnings Call Presentation Veralto rated Sector ...
2023-11-02 11:35:06 ET Summary GE HealthCare's revenue growth is expected to benefit from healthy order bookings and backlog levels, along with easing supply chain challenges. The company's revenues should also benefit from volume growth fueled by good end-market demand and strong...
2023-11-02 10:00:00 ET Summary Roper has divested inferior businesses and focused on higher quality ones, leading to improved margins and cash conversion. The company now has 70% of its sales as recurring or reoccurring, resulting in negative net working capital. Roper's valua...
Danaher appoints Christopher Riley to Executive Vice President for Biotechnology PR Newswire WASHINGTON , Oct. 31, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, to...
2023-10-30 12:28:25 ET More on Revvity Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade) Revvity, Inc. (RVTY) Q2 2023 Earnings Call Transcript Revvity, Inc. 2023 Q2 - Results - Earnings Call Presentation Revvity misses ...
2023-10-27 13:21:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The market selloff that began in August is accelerating, with the technology-laden Nasdaq Composite Index having fallen into correction territory, which means it is down over 10% from i...
2023-10-26 15:24:51 ET Summary Veralto Corporation, a $5 billion water and product quality business, was spun off from parent company Danaher Corporation. Shares of Veralto have fallen 20% since the spinoff, but still trades at a small premium. The company's growth is underwhe...
2023-10-26 15:06:00 ET More on Abcam ADS Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold Abcam holders should vote for sale to Danaher, proxy adviser ISS says (update) Abcam received multiple bids in sales process, contacted ove...
2023-10-26 09:15:02 ET Summary Danaher Corporation, with a focus on biotechnology and life sciences, exhibits strong long-term growth potential, supported by its diverse segments and innovation-driven approach. Danaher's recent financial performance has faced challenges, particula...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...